Although a causal relationship between excess growth hormone (GH) or insulin-like growth factor 1 (IGF-1) and schwannoma development cannot be established from a single case, this association is hypothesis-generating and highlights the need for careful head and neck evaluation in patients with endocrine disorders. This evidence concerns the gene GH1 and schwannoma.